Reactive infectious mucocutaneous eruption triggered by rhinovirus and β-haemolytic streptococcus co-infection
- 2 May 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (9) , 1748-1750
Abstract
We describe a reactive infectious mucocutaneous eruption (RIME) triggered by co-infection with rhinovirus and β-haemolytic streptococcus. This presentation suggests that distinct pathogens may act synergistically to produce a powerful host immunological response, resulting in striking mucocutaneous clinical features. Our case illustrates the importance of screening for a broad range of respiratory pathogens, as positive findings may aid in the diagnosis of RIME and inform the choice of targeted antimicrobial therapy.Keywords
This publication has 5 references indexed in Scilit:
- Reactive Infectious Mucocutaneous Eruption (RIME): Narrative Review and Proposed Management AlgorithmDermatology Practical & Conceptual, 2025
- A severe case of reactive infectious mucocutaneous eruption associated with two possible triggers: Coronavirus and group A streptococcusPediatric Dermatology, 2024
- Recurrent reactive infectious mucocutaneous eruption in a male adult patient associated with Mycoplasma pneumoniae, SARS-CoV-2 and rhinovirusBMJ Case Reports, 2023
- Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza APediatric Dermatology, 2021
- Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three episodesPediatric Dermatology, 2020